King Pharmaceuticals Voluntarily Recalls Embeda

The American Pain Foundation announced on Tuesday that King Pharmaceuticals is voluntarily recalling all dosage forms of Embeda (morphine sulfate with naltrexone hydrochloride) because of failure to meet stability requirements in routine testing. Embed… more »